{
    "clinical_study": {
        "@rank": "102513", 
        "acronym": "PATHWAYS I", 
        "arm_group": [
            {
                "arm_group_label": "CAT-2003 or Placebo Dose 1", 
                "arm_group_type": "Experimental", 
                "description": "Daily for 28 days in patients with moderate hypertriglyceridemia"
            }, 
            {
                "arm_group_label": "CAT-2003 or Placebo Dose 2", 
                "arm_group_type": "Experimental", 
                "description": "Daily for 28 days in patients with moderate hypertriglyceridemia"
            }, 
            {
                "arm_group_label": "CAT-2003 or Placebo Dose 3", 
                "arm_group_type": "Experimental", 
                "description": "Daily for 28 days in patients with moderate hypertriglyceridemia"
            }, 
            {
                "arm_group_label": "CAT-2003 or Placebo Dose 4", 
                "arm_group_type": "Experimental", 
                "description": "Daily for 28 days in patients with hypercholesterolemia who are on a statin"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the safety and efficacy of different doses of\n      CAT-2003 in patients with hyperlipidemia when CAT-2003 is taken for 4 weeks. The study will\n      evaluate effects of CAT-2003 on (1) fasting triglycerides and non-HDL-C in patients with\n      moderate hypertriglyceridemia and (2) fasting LDL-C levels in combination with a statin in\n      patients with hypercholesterolemia who are on a statin."
        }, 
        "brief_title": "Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Dyslipidemia", 
            "Hypercholesterolemia", 
            "Hypertriglyceridemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypercholesterolemia", 
                "Hyperlipidemias", 
                "Hypertriglyceridemia", 
                "Dyslipidemias"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between 18 and 69 years at Screening\n\n          -  Hypertriglyceridemia (TG \u2265 200 mg/dL and < 500 mg/dL and non-HDL-C \u2265 100 mg/dL and <\n             220 mg/dL) OR\n\n          -  Hypercholesterolemia (LDL-C \u2265 100 mg/dL and < 190 mg/dL and TG value < 200 mg/dL)\n             plus a stable dose of statin for at least 4 weeks prior to Screening.\n\n          -  Body mass index (BMI) \u2264 45 kg/m2\n\n        Exclusion Criteria:\n\n          -  History of any major cardiovascular event within 6 months of Screening\n\n          -  Type I  diabetes mellitus\n\n          -  Any condition that may predispose the patient to secondary hyperlipidemia, such as\n             uncontrolled hypothyroidism\n\n          -  Any statin at the highest approved dose\n\n          -  Non-statin lipid-altering drugs other than cholesterol absorption inhibitors.\n\n          -  Active peptic ulcer disease or a history of muscle disease or myopathy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "99", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01912560", 
            "org_study_id": "CAT-2003-201"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "CAT-2003 or Placebo Dose 1", 
                    "CAT-2003 or Placebo Dose 2", 
                    "CAT-2003 or Placebo Dose 3", 
                    "CAT-2003 or Placebo Dose 4"
                ], 
                "intervention_name": "CAT-2003", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "CAT-2003 or Placebo Dose 1", 
                    "CAT-2003 or Placebo Dose 2", 
                    "CAT-2003 or Placebo Dose 3", 
                    "CAT-2003 or Placebo Dose 4"
                ], 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Muscle Shoals", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35662"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90057"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32223"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winter Park", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32792"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40213"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auburn", 
                        "country": "United States", 
                        "state": "Maine", 
                        "zip": "04120"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27609"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27612"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45227"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45219"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45246"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sainte-Foy", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "G1V 4M6"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Safety, Efficacy and Pharmacodynamics of CAT-2003 Alone and In Combination With A Statin in Patients With Hyperlipidemia (PATHWAYS I)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Absolute and percent change from baseline in plasma triglycerides in patients with hypertriglyceridemia", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "Absolute and percent change from baseline in plasma low density lipoprotein-cholesterol in patients with hypercholesterolemia", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01912560"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Absolute and percent change from baseline in plasma non-high-density lipoprotein cholesterol", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "Pharmacodynamic effects of CAT-2003 on other lipid biomarkers in patients with hyperlipidemia", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Safety and tolerability will be assessed for all enrolled patients from the time the patient signs the informed consent through post-treatment follow-up. Safety parameters include physical exam, vital signs, clinical laboratory tests, ECGs and concomitant medications.", 
                "measure": "Frequency of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "4 weeks"
            }
        ], 
        "source": "Catabasis Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Catabasis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}